Want To Stay Up-To-Date On The Latest 340B News?
"*" indicates required fields
Posted on October 28, 2015 |
Up to a third of hospitals currently participating in the 340B drug-pricing program say they would consider opting out if proposed regulatory changes are finalized, a leading advocacy group said on Wednesday.
More than a quarter of the 2,100 hospitals that participate in the drug-discount program would be significantly affected by the provisions included within the Health Resources and Services Administration’s draft omnibus guidance released in August, according to the advocacy group 340B Health.